Fundz

Resilient Biotics reported raising $2.36 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEAug 19, 2022$2.4M of $3M raised

Amount Raised

$2.36 Million

$2.36 Million sold, per SEC Form D (first sale Aug 16, 2022)

Round Type

Seed

Research Triangle ParkBiotechnology

Who to call at Resilient Biotics, and when

A new round usually means Resilient Biotics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Resilient Biotics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Resilient Biotics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Resilient Biotics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Resilient Biotics

Location

2 DAVIS DRIVE

Research Triangle Park, North Carolina, United States

About

Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. The company utilizes a proprietary discovery platform that incorporates high resolution genomic analyses, in-house machine learning algorithms, and targeted in vitro assays to identify naturally occurring microbiome-derived strains that have immune activation and pathogen inhibition properties in respiratory tissues. Resilient Biotics has a broad pipeline of actives addressing both viral and bacterial infectious diseases including positive in vivo efficacy data across multiple species.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Resilient Biotics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChristopher B., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Resilient Biotics's next move

See what Strategic adds

Resilient Biotics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.